Aurinia Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Aurinia Pharmaceuticals's estimated annual revenue is currently $55.6M per year.
- Aurinia Pharmaceuticals's estimated revenue per employee is $176,092
- Aurinia Pharmaceuticals's total funding is $658.5M.
Employee Data
- Aurinia Pharmaceuticals has 316 Employees.
- Aurinia Pharmaceuticals grew their employee count by -1% last year.
Aurinia Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
2 | Chief Medical Officer and co-founder | Reveal Email/Phone |
3 | COO | Reveal Email/Phone |
4 | CEO | Reveal Email/Phone |
5 | Chief Commercial Officer | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | CEO | Reveal Email/Phone |
8 | Chief Information Officer | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Chief Financial Officer | Reveal Email/Phone |
Aurinia Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.1M | 40 | 18% | $40M | N/A |
#2 | $0.2M | 2 | 0% | N/A | N/A |
#3 | $1.3M | 17 | -15% | N/A | N/A |
#4 | $2.6M | 17 | 6% | N/A | N/A |
#5 | $12.9M | 83 | 5% | N/A | N/A |
#6 | $1.9M | 24 | 4% | $89.5M | N/A |
#7 | $2.8M | 18 | 6% | N/A | N/A |
#8 | $40.3M | 260 | 21% | N/A | N/A |
#9 | $0.9M | 6 | 0% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis, focal segmental glomerulosclerosis, and Dry Eye Syndrome. The company is headquartered in Victoria, British Columbia and focuses its development efforts globally. For further information, see our website at www.auriniapharma.com.
keywords:N/A
$658.5M
Total Funding
316
Number of Employees
$55.6M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aurinia Pharmaceuticals News
SAN DIEGO, April 23, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Aurinia Pharmaceuticals...
NEW YORK, April 23, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Aurinia Pharmaceuticals...
Levi & Korsinsky, LLP notifies investors in Aurinia Pharmaceuticals Inc. of a class action securities lawsuit.The lawsuit on behalf of...
Other Companies in Victoria
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $65.3M | 373 | 213% | N/A |
#2 | $77.6M | 376 | 29% | N/A |
#3 | $70M | 386 | -8% | N/A |
#4 | $15M | 405 | N/A | N/A |
#5 | $15M | 428 | 0% | N/A |